Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Scansource
SCSC
$1.15B
| $437K | ﹤0.01% |
11,052
-20
| -0.2% | -$673 |
|
2052
RxSight
RXST
$252M
| $437K | ﹤0.01% |
10,844
-10
| -0.1% | -$293 |
|
2053
Lemonade
LMND
$3.76B
| $437K | ﹤0.01% |
27,106
-36
| -0.1% | -$542 |
|
2054
1st Source
SRCE
$2.16B
| $436K | ﹤0.01% |
7,935
-7
| -0.1% | -$336 |
|
2055
Nu Skin
NUS
$254M
| $434K | ﹤0.01% |
22,326
-42
| -0.2% | -$775 |
|
2056
CVR Energy
CVI
$3.83B
| $433K | ﹤0.01% |
14,285
-24
| -0.2% | -$758 |
|
|
INBX
2057
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $432K | ﹤0.01% |
11,358
-17
| -0.1% | -$364 |
|
2058
Monro
MNRO
$421M
| $429K | ﹤0.01% |
14,601
-25
| -0.2% | -$703 |
|
|
DMC
2059
Del Monte Corp
DMC
$1.41B
| $429K | ﹤0.01% |
16,327
-30
| -0.2% | -$739 |
|
2060
Southside Bancshares
SBSI
$960M
| $428K | ﹤0.01% |
13,678
-26
| -0.2% | -$756 |
|
|
DCPH
2061
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $428K | ﹤0.01% |
26,537
-90
| -0.3% | -$1.15K |
|
2062
Perella Weinberg Partners
PWP
$1.09B
| $426K | ﹤0.01% |
34,853
+12,032
| +53% | +$131K |
|
2063
Eagle Bancorp
EGBN
$838M
| $425K | ﹤0.01% |
14,136
-23
| -0.2% | -$543 |
|
2064
Ichor Holdings
ICHR
$2.61B
| $425K | ﹤0.01% |
12,632
-21
| -0.2% | -$581 |
|
2065
Hovnanian Enterprises
HOV
$758M
| $425K | ﹤0.01% |
+2,724
| New | +$274K |
|
2066
Symbotic
SYM
$5.46B
| $423K | ﹤0.01% |
8,231
+23
| +0.3% | +$1.01K |
|
2067
Graco
GGG
$13B
| $422K | ﹤0.01% |
4,864
-133
| -3% | -$10.5K |
|
2068
ADMA Biologics
ADMA
$2.01B
| $422K | ﹤0.01% |
93,272
-147
| -0.2% | -$544 |
|
2069
Hain Celestial
HAIN
$44.4M
| $422K | ﹤0.01% |
38,532
-69
| -0.2% | -$745 |
|
2070
Compass
COMP
$8.56B
| $421K | ﹤0.01% |
111,834
-134
| -0.1% | -$331 |
|
2071
Leonardo DRS
DRS
$12.2B
| $419K | ﹤0.01% |
20,894
+5
| +0% | +$94 |
|
2072
AMC Entertainment Holdings
AMC
$2.47B
| $419K | ﹤0.01% |
68,453
+509
| +0.7% | +$4.13K |
|
2073
Warby Parker
WRBY
$3.19B
| $418K | ﹤0.01% |
29,623
-59
| -0.2% | -$735 |
|
2074
Vaalco Energy
EGY
$567M
| $418K | ﹤0.01% |
93,050
+4,280
| +5% | +$18.8K |
|
2075
Southern Copper
SCCO
$145B
| $417K | ﹤0.01% |
5,221
-73
| -1% | -$5.08K |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.